ClinicalTrials.gov record
Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
ClinicalTrials.gov ID: NCT00084266
Public ClinicalTrials.gov record NCT00084266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Linezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine if linezolid is superior to vancomycin in the treatment of nosocomial (acquired in the hospital) pneumonia due to Methicillin Resistant Staphylococcus Aureus (MRSA) in adult subjects. Subjects entered in to the study will have proven healthcare-associated methicillin-resistant Staphylococcus aureus pneumonia which will be treated with either linezolid or vancomycin.
Study identification
- NCT ID
- NCT00084266
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,225 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2004 (Type not available)
- Primary completion
- Mar 2010 (Actual)
- Completion
- Mar 2010 (Actual)
- Last update posted
- Feb 1, 2012
2004 – 2010
United States locations
- U.S. sites
- 108
- U.S. states
- 32
- U.S. cities
- 74
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35233 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35249 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35294 | — |
| Pfizer Investigational Site | Huntsville | Alabama | 35801 | — |
| Pfizer Investigational Site | Montgomery | Alabama | 36106 | — |
| Pfizer Investigational Site | Montgomery | Alabama | 36111 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85013 | — |
| Pfizer Investigational Site | Los Angeles | California | 90033 | — |
| Pfizer Investigational Site | Orange | California | 92868 | — |
| Pfizer Investigational Site | Redlands | California | 92373 | — |
| Pfizer Investigational Site | Sacramento | California | 95817 | — |
| Pfizer Investigational Site | San Diego | California | 92120 | — |
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | San Francisco | California | 94110 | — |
| Pfizer Investigational Site | Denver | Colorado | 80204 | — |
| Pfizer Investigational Site | Denver | Colorado | 80205 | — |
| Pfizer Investigational Site | Denver | Colorado | 80218 | — |
| Pfizer Investigational Site | Newark | Delaware | 19718 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20017 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20037 | — |
| Pfizer Investigational Site | Brandon | Florida | 33511 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33316 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32610 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32209 | — |
| Pfizer Investigational Site | Jackson | Florida | 32209 | — |
| Pfizer Investigational Site | Miami | Florida | 33136 | — |
| Pfizer Investigational Site | Orlando | Florida | 32801 | — |
| Pfizer Investigational Site | Orlando | Florida | 32806 | — |
| Pfizer Investigational Site | Tampa | Florida | 33607 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30909 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30912 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30030 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Honolulu | Hawaii | 96817 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60612 | — |
| Pfizer Investigational Site | North Chicago | Illinois | 60064 | — |
| Pfizer Investigational Site | Oak Park | Illinois | 60302-2566 | — |
| Pfizer Investigational Site | Springfield | Illinois | 62701 | — |
| Pfizer Investigational Site | Springfield | Illinois | 62702 | — |
| Pfizer Investigational Site | Springfield | Illinois | 62703 | — |
| Pfizer Investigational Site | New Albany | Indiana | 47151 | — |
| Pfizer Investigational Site | Hazard | Kentucky | 41701 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40536 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40202 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40206 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21201 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02111 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02114 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02115 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02118 | — |
| Pfizer Investigational Site | Springfield | Massachusetts | 01199 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48109-0331 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48201 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48202 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48210 | — |
| Pfizer Investigational Site | Saint Loius | Missouri | 63110 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63110-1010 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63110 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68131 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89109 | — |
| Pfizer Investigational Site | Reno | Nevada | 89502 | — |
| Pfizer Investigational Site | Reno | Nevada | 89503 | — |
| Pfizer Investigational Site | Hackensack | New Jersey | 07601 | — |
| Pfizer Investigational Site | Albany | New York | 12208 | — |
| Pfizer Investigational Site | Brooklyn | New York | 11215 | — |
| Pfizer Investigational Site | Buffalo | New York | 14215 | — |
| Pfizer Investigational Site | New York | New York | 10011 | — |
| Pfizer Investigational Site | New York | New York | 10021-9800 | — |
| Pfizer Investigational Site | New York | New York | 10029 | — |
| Pfizer Investigational Site | Rochester | New York | 14642-8410 | — |
| Pfizer Investigational Site | Rochester | New York | 14642 | — |
| Pfizer Investigational Site | The Bronx | New York | 10457 | — |
| Pfizer Investigational Site | Greensboro | North Carolina | 27401 | — |
| Pfizer Investigational Site | Fargo | North Dakota | 58112 | — |
| Pfizer Investigational Site | Fargo | North Dakota | 58122 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45219 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45267-0558 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43210 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43214 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43215 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43222 | — |
| Pfizer Investigational Site | Sylvania | Ohio | 43560 | — |
| Pfizer Investigational Site | Toledo | Ohio | 43608 | — |
| Pfizer Investigational Site | Toledo | Ohio | 43614 | — |
| Pfizer Investigational Site | Portland | Oregon | 97213 | — |
| Pfizer Investigational Site | Portland | Oregon | 97220 | — |
| Pfizer Investigational Site | Abington | Pennsylvania | 19001 | — |
| Pfizer Investigational Site | Allentown | Pennsylvania | 18103 | — |
| Pfizer Investigational Site | Bethlehem | Pennsylvania | 18017 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19102 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| Pfizer Investigational Site | Providence | Rhode Island | 02903 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29425 | — |
| Pfizer Investigational Site | Sioux Falls | South Dakota | 57104 | — |
| Pfizer Investigational Site | Sioux Falls | South Dakota | 57105 | — |
| Pfizer Investigational Site | Sioux Falls | South Dakota | 57117-5045 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37232-7110 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37232 | — |
| Pfizer Investigational Site | Houston | Texas | 77030-1608 | — |
| Pfizer Investigational Site | Irving | Texas | 75061 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78284 | — |
| Pfizer Investigational Site | San Marcos | Texas | 78666 | — |
| Pfizer Investigational Site | Sequin | Texas | 78155 | — |
| Pfizer Investigational Site | Temple | Texas | 76508 | — |
| Pfizer Investigational Site | Murray | Utah | 84157 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23219 | — |
| Pfizer Investigational Site | Winchester | Virginia | 22601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00084266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00084266 live on ClinicalTrials.gov.